Nome Químico: Ethyl 3-(1-methyl-2-(((4-(N-((octyloxy)carbonyl)carbamimidoyl)phenyl)amino)methyl)-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate
Sorrisos: CN1C(C=CC(C(N(C2=CC=CC=N2)CCC(OCC)=O)=O)=C3)=C3N=C1CNC4=CC=C(C(NC(OCCCCCCCC)=O)=N)C=C4
Inchi: InChI=1/C19H19N3O/c1-12-10-14(11-22-9-8-20-13(22)2)19(23)17-15-6-4-5-7-16(15)21(3)18(12)17/h4-9,14H,1,10-11H2,2-3H3
Novel method for separation and quantification of potential impurities by RP-HPLC from KSM stage to API stage of dabigatran mesylate
By Jhansi, T. Naga; Nagaraju, R.; Kumar, D. Jaya Deep; Rao, G. Nageswara
From International Journal of Pharmaceutical Sciences and Research (2021), 12(3), 1762-1779
Development and Validation of RP-UPLC Method for the Determination of Process and Degradant Impurities Present in Dabigatran Etexilate Mesylate Capsules Using High Strength Silica-T3 Sorbent Column
By Mantena, Bhaskara P. V.; Rao, Sumathi V.; Suryakala, D.; Ramakrishna, K.; Srikanth Reddy, R.
From Analytical Chemistry Letters (2016), 6(5), 595-611
Determination of dabigatran etexilate mesylate by HPLC
By Jia, Ling-xiao; Tang, Lei; Zhang, Shu-ting; Song, Rui-zhi; Gao, Zhan-wen
From Shipin Yu Yaopin (2015), 17(3), 195-197